Relife Pharmaceuticals Opc Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Revenue Growth 19.49%
- Profit Growth 20.65%
- Ebitda 5.15%
- Net Worth 51.84%
- Total Assets -5.53%
About Relife Pharmaceuticals Opc
Relife Pharmaceuticals Opc Private Limited (RPOPL) is a Company incorporated in India on 16 February 2016 (Eight years and 11 months 16 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.00 Cr.
Santosh Shah serves as a director at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52100WB2016OPC209749
-
Company No.
209749
-
Incorporation Date
16 Feb 2016
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Relife Pharmaceuticals Opc Private Limited offer?
Relife Pharmaceuticals Opc Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Animal Medicines & Health Care, Veterinary Injections, Fertilizers and Soil Additives, Plant Growth Promoters, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Relife Pharmaceuticals Opc?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Shah
|
Director | 16-Feb-2016 | Current |
Financial Performance of Relife Pharmaceuticals Opc.
Relife Pharmaceuticals Opc Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.49% increase. The company also saw a substantial improvement in profitability, with a 20.65% increase in profit. The company's net worth Soared by an impressive increase of 51.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relife Pharmaceuticals Opc?
Unlock access to Relife Pharmaceuticals Opc's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹50.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Others | ₹2.50 Cr | Open |
| 28 Dec 2023 | Others | ₹2.50 Cr | Open |
How Many Employees Work at Relife Pharmaceuticals Opc?
Relife Pharmaceuticals Opc has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relife Pharmaceuticals Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relife Pharmaceuticals Opc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
